Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karsten Midtvedt

Showing results (51-60 of 153) with videos related to

Pageof 16
Sort By:
Transplantation Direct|June 24, 2024
Long-term Outcomes After Kidney Transplantation From DBD Donors Aged 70 y and OlderJørn Petter Lindahl, Anders Åsberg, Kristian Heldal, et al.
British Journal of Clinical Pharmacology|August 3, 2023
Clinical performance of volumetric finger-prick sampling for the monitoring of tacrolimus, creatinine and haemoglobin in kidney transplant recipientsNils Tore Vethe, Anders Åsberg, Anders Mikal Andersen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 17, 2008
Long-term clinical outcome of paediatric kidneys transplanted to adultsAksel Foss, Anne Gunther, Pål-Dag Line, et al.
Therapeutic Drug Monitoring|March 11, 2010
Computer-assisted cyclosporine dosing performs better than traditional dosing in renal transplant recipients: results of a pilot studyAnders Asberg, Pål Falck, Liv H Undset, et al.
British Journal of Clinical Pharmacology|July 8, 2017
NFAT-regulated cytokine gene expression during tacrolimus therapy early after renal transplantationSara Bremer, Nils T Vethe, Morten Skauby, et al.
European Journal of Clinical Pharmacology|March 25, 2014
The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipientsIngrid Lunde, Sara Bremer, Karsten Midtvedt, et al.
Arthritis and Rheumatism|March 2, 2011
Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantationGudrun E Norby, Torbjørn Leivestad, Geir Mjøen, et al.
Clinical Pharmacokinetics|September 4, 2009
A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipientsPål Falck, Karsten Midtvedt, Thanh Trúc Vân Lê, et al.
Transplantation Research|June 27, 2013
Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational studyKristian Heldal, Solveig Thorarinsdottir, Anders Hartmann, et al.
Transplantation|November 19, 2016
Are Octogenarians With End-Stage Renal Disease Candidates for Renal Transplantation?Kjersti Lønning, Karsten Midtvedt, Torbjørn Leivestad, et al.
Pageof 16

Showing results (51-60 of 153) with videos related to

Sort By:
Pageof 16
Transplantation Direct|June 24, 2024
Long-term Outcomes After Kidney Transplantation From DBD Donors Aged 70 y and OlderJørn Petter Lindahl, Anders Åsberg, Kristian Heldal, et al.
British Journal of Clinical Pharmacology|August 3, 2023
Clinical performance of volumetric finger-prick sampling for the monitoring of tacrolimus, creatinine and haemoglobin in kidney transplant recipientsNils Tore Vethe, Anders Åsberg, Anders Mikal Andersen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 17, 2008
Long-term clinical outcome of paediatric kidneys transplanted to adultsAksel Foss, Anne Gunther, Pål-Dag Line, et al.
Therapeutic Drug Monitoring|March 11, 2010
Computer-assisted cyclosporine dosing performs better than traditional dosing in renal transplant recipients: results of a pilot studyAnders Asberg, Pål Falck, Liv H Undset, et al.
British Journal of Clinical Pharmacology|July 8, 2017
NFAT-regulated cytokine gene expression during tacrolimus therapy early after renal transplantationSara Bremer, Nils T Vethe, Morten Skauby, et al.
European Journal of Clinical Pharmacology|March 25, 2014
The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipientsIngrid Lunde, Sara Bremer, Karsten Midtvedt, et al.
Arthritis and Rheumatism|March 2, 2011
Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantationGudrun E Norby, Torbjørn Leivestad, Geir Mjøen, et al.
Clinical Pharmacokinetics|September 4, 2009
A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipientsPål Falck, Karsten Midtvedt, Thanh Trúc Vân Lê, et al.
Transplantation Research|June 27, 2013
Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational studyKristian Heldal, Solveig Thorarinsdottir, Anders Hartmann, et al.
Transplantation|November 19, 2016
Are Octogenarians With End-Stage Renal Disease Candidates for Renal Transplantation?Kjersti Lønning, Karsten Midtvedt, Torbjørn Leivestad, et al.
Pageof 16